CPCAY vs KYMR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CPCAY · CATHAY PACIFIC AIR$9.55 ▼ 1.55%
KYMR · Kymera Therapeutics$131.73 ▲ 2.82%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CPCAY +35.8%
- KYMR +115.0%
Head to head
| Metric | CPCAY | KYMR |
|---|---|---|
| Price | $9.55 | $131.73 |
| Change today | ▼ 1.55% | ▲ 2.82% |
| Market cap | $11.25B | $11.25B |
| Return, 3 months | +2.6% | +21.3% |
| Return, year to date | +29.5% | +69.3% |
| Return, 1 year | +35.5% | +124.6% |
| P/E (TTM) | 7.2 | – |
| P/B | 1.6 | 7.0 |
| P/E percentile vs own 5y | – | 3rd |
| Dividend yield | 6.00% | – |
| Revenue growth (YoY, latest qtr) | – | -100.0% |
| Net profit growth (YoY) | – | -60.6% |
| Gross margin | – | – |
| Operating margin | – | -396.0% |
| Net margin | – | -341.8% |
| Return on equity | – | -27.3% |
| Analyst target vs. price | – | +9.2% |
| Analyst buy share | – | 94% |
| RSI (14) | 64 | 65 |
| 30-day volatility | 36.0% | 46.3% |
| Max drawdown, 1 year | -13.8% | -27.7% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CPCAY is the largest of the group by market value.
- KYMR has returned the most over the past year.
- CPCAY has been the calmest stock over the last 30 days.